TP53 and neoplasm: With our better understanding of the immunological component of anti-tumor effects of p53 activation, these small molecules will be valuable tools for evaluating the immunological impact of p53 reactivation in various compartments of the TME, such as tumor or CAFs, both have been shown to incur p53 mutations independent of each other.